Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial

Michael E Nassif; Sheryl Windsor; Fengming Tang; Yevgeniy Khariton; Mansoor Husain; Silvio E Inzucchi; Darren McGuire; Bertram Pitt; Benjamin M Scirica; Bethany Austin; Mark Drazner; Michael Fong; Michael M Givertz; Robert Gordon; Rita Jermyn; Stuart Katz; Sumant Lamba; David E Lanfear; Shane LaRue; JoAnn Lindenfeld; Michael Malone; Kenneth B Margulies; Robert Mentz; R K Mutharasan; Michael Pursley; Guillermo Umpierrez; Mikhail Kosiborod

Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial

Michael E Nassif
, Sheryl Windsor
, Fengming Tang
, Yevgeniy Khariton
, Mansoor Husain
, Silvio E Inzucchi
, Darren McGuire
, Bertram Pitt
, Benjamin M Scirica
, Bethany Austin
, Mark Drazner
, Michael Fong
, Michael M Givertz
, Robert Gordon
, Rita Jermyn
, Stuart Katz
, Sumant Lamba
, David E Lanfear
, Shane LaRue
, JoAnn Lindenfeld

Michael Malone, Kenneth B Margulies, Robert Mentz, R K Mutharasan, Michael Pursley, Guillermo Umpierrez, Mikhail Kosiborod

Henry Ford Health

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Cardiology Articles
State	Published - Sep 16 2019

Access to Document

Cite this

Nassif, M. E., Windsor, S., Tang, F., Khariton, Y., Husain, M., Inzucchi, S. E., McGuire, D., Pitt, B., Scirica, B. M., Austin, B., Drazner, M., Fong, M., Givertz, M. M., Gordon, R., Jermyn, R., Katz, S., Lamba, S., Lanfear, D. E., LaRue, S., ... Kosiborod, M. (2019). Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial. Cardiology Articles. http://sfxhosted.exlibrisgroup.com/hfhs?sid=Entrez:PubMed&id=pmid:31524498

Nassif, ME, Windsor, S, Tang, F, Khariton, Y, Husain, M, Inzucchi, SE, McGuire, D, Pitt, B, Scirica, BM, Austin, B, Drazner, M, Fong, M, Givertz, MM, Gordon, R, Jermyn, R, Katz, S, Lamba, S, Lanfear, DE, LaRue, S, Lindenfeld, J, Malone, M, Margulies, KB, Mentz, R, Mutharasan, RK, Pursley, M, Umpierrez, G & Kosiborod, M 2019, 'Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial', Cardiology Articles. <http://sfxhosted.exlibrisgroup.com/hfhs?sid=Entrez:PubMed&id=pmid:31524498>

@article{4f39ecf3e7224a7cac2150bc1b41f0ec,

title = "Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial",

author = "Nassif, \{Michael E\} and Sheryl Windsor and Fengming Tang and Yevgeniy Khariton and Mansoor Husain and Inzucchi, \{Silvio E\} and Darren McGuire and Bertram Pitt and Scirica, \{Benjamin M\} and Bethany Austin and Mark Drazner and Michael Fong and Givertz, \{Michael M\} and Robert Gordon and Rita Jermyn and Stuart Katz and Sumant Lamba and Lanfear, \{David E\} and Shane LaRue and JoAnn Lindenfeld and Michael Malone and Margulies, \{Kenneth B\} and Robert Mentz and Mutharasan, \{R K\} and Michael Pursley and Guillermo Umpierrez and Mikhail Kosiborod",

note = "Nassif ME, Windsor S, Tang F, Khariton Y, Husain M, Inzucchi SE, McGuire D, Pitt B, Scirica BM, Austin B, Drazner M, Fong M, Givertz MM, Gordon R, Jermyn R, Katz S, Lamba S, Lanfear D, LaRue S, Lindenfeld J, Malone M, Margulies KB, Mentz R, Mutharasan RK, Pursley M, Umpierrez G, and Kosiborod M. Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial. Circulation 2019.",

year = "2019",

month = sep,

day = "16",

language = "American English",

journal = "Cardiology Articles",

issn = "1524-4539",

}

TY - JOUR

T1 - Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial

AU - Nassif, Michael E

AU - Windsor, Sheryl

AU - Tang, Fengming

AU - Khariton, Yevgeniy

AU - Husain, Mansoor

AU - Inzucchi, Silvio E

AU - McGuire, Darren

AU - Pitt, Bertram

AU - Scirica, Benjamin M

AU - Austin, Bethany

AU - Drazner, Mark

AU - Fong, Michael

AU - Givertz, Michael M

AU - Gordon, Robert

AU - Jermyn, Rita

AU - Katz, Stuart

AU - Lamba, Sumant

AU - Lanfear, David E

AU - LaRue, Shane

AU - Lindenfeld, JoAnn

AU - Malone, Michael

AU - Margulies, Kenneth B

AU - Mentz, Robert

AU - Mutharasan, R K

AU - Pursley, Michael

AU - Umpierrez, Guillermo

AU - Kosiborod, Mikhail

N1 - Nassif ME, Windsor S, Tang F, Khariton Y, Husain M, Inzucchi SE, McGuire D, Pitt B, Scirica BM, Austin B, Drazner M, Fong M, Givertz MM, Gordon R, Jermyn R, Katz S, Lamba S, Lanfear D, LaRue S, Lindenfeld J, Malone M, Margulies KB, Mentz R, Mutharasan RK, Pursley M, Umpierrez G, and Kosiborod M. Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial. Circulation 2019.

PY - 2019/9/16

Y1 - 2019/9/16

UR - https://scholarlycommons.henryford.com/cardiology_articles/490

UR - http://sfxhosted.exlibrisgroup.com/hfhs?sid=Entrez:PubMed&id=pmid:31524498

M3 - Article

SN - 1524-4539

JO - Cardiology Articles

JF - Cardiology Articles

ER -

Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial

Access to Document

Other files and links

Cite this